Author Correction: Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial.
Laurence BuisseretDelphine LoiratPhilippe AftimosChristian MaurerKevin PunieVéronique DebienPaulus KristantoDaniel EigerAnthony GoncalvesFrançois GhiringhelliDonatienne TaylorFlorent ClatotTom Van den MooterJean-Marc FerreroHervé BonnefoiJean-Luc CanonFran Ois P DuhouxLaura MansiRenaud PoncinPhilippe BarthélémyNicolas IsambertZoë DenisXavier CatteauRoberto SalgadoElisa AgostinettoEvandro de AzambujaFrançoise RothéLigia CraciunDavid VenetEmanuela RomanoJohn StaggMarianne PaesmansDenis LarsimontChristos SotiriouMichail IgnatiadisMartine J PiccartPublished in: Nature communications (2023)